<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1136/archdischild-2021-322463</dc:identifier><dc:language>eng</dc:language><dc:creator>Bauerl, C..</dc:creator><dc:creator>Randazzo, W.</dc:creator><dc:creator>Sánchez, G.</dc:creator><dc:creator>Selma-Royo, M.</dc:creator><dc:creator>García Verdevio, E.</dc:creator><dc:creator>Martínez, L.</dc:creator><dc:creator>Parra-Llorca, A.</dc:creator><dc:creator>Lerín, C.</dc:creator><dc:creator>Fumadó, V.</dc:creator><dc:creator>Crovetto, F.</dc:creator><dc:creator>Crispi, F.</dc:creator><dc:creator>Pérez-Cano, F. J.</dc:creator><dc:creator>Rodríguez, G.</dc:creator><dc:creator>Ruiz-Redondo, G.</dc:creator><dc:creator>Campoy, C.</dc:creator><dc:creator>Martínez-Costa, C.</dc:creator><dc:creator>Collado, M. C. on behalf of MilkCORONA study team</dc:creator><dc:title>SARS-CoV-2 RNA and antibody detection in breast milk from a prospective multicentre study in Spain</dc:title><dc:identifier>ART-2022-125742</dc:identifier><dc:description>Objectives: To develop and validate a specific protocol for SARS-CoV-2 detection in breast milk matrix and to determine the impact of maternal SARS-CoV-2 infection on the presence, concentration and persistence of specific SARS-CoV-2 antibodies. Design and patients: This is a prospective, multicentre longitudinal study (April–December 2020) in 60 mothers with SARS-CoV-2 infection and/or who have recovered from COVID-19. A control group of 13 women before the pandemic were also included. Setting: Seven health centres from different provinces in Spain. Main outcome measures: Presence of SARS-CoV-2 RNA in breast milk, targeting the N1 region of the nucleocapsid gene and the envelope (E) gene; presence and levels of SARS-CoV-2-specific immunoglobulins (Igs)—IgA, IgG and IgM—in breast milk samples from patients with COVID-19. Results: All breast milk samples showed negative results for presence of SARS-CoV-2 RNA. We observed high intraindividual and interindividual variability in the antibody response to the receptor-binding domain of the SARS-CoV-2 spike protein for each of the three isotypes IgA, IgM and IgG. Main Protease (MPro) domain antibodies were also detected in milk. 82.9% (58 of 70) of milk samples were positive for at least one of the three antibody isotypes, with 52.9% of these positive for all three Igs. Positivity rate for IgA was relatively stable over time (65.2%–87.5%), whereas it raised continuously for IgG (from 47.8% for the first 10 days to 87.5% from day 41 up to day 206 post-PCR confirmation). Conclusions: Our study confirms the safety of breast feeding and highlights the relevance of virus-specific SARS-CoV-2 antibody transfer. This study provides crucial data to support official breastfeeding recommendations based on scientific evidence.</dc:description><dc:date>2022</dc:date><dc:source>http://zaguan.unizar.es/record/109583</dc:source><dc:doi>10.1136/archdischild-2021-322463</dc:doi><dc:identifier>http://zaguan.unizar.es/record/109583</dc:identifier><dc:identifier>oai:zaguan.unizar.es:109583</dc:identifier><dc:identifier.citation>Archives of Disease in Childhood-Fetal and Neonatal Edition 107, 2 (2022), 217-221</dc:identifier.citation><dc:rights>by-nc</dc:rights><dc:rights>http://creativecommons.org/licenses/by-nc/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>